Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Beyang

Beyang

Series AUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$30.0Msum of rounds with a disclosed amount only
Named investors
8
Financing history
1 rounds
  1. Aug 12, 2026
    Series A · $30.0M (disclosed)
    Legend Capital (lead)Shanghai Healthcare Capital (lead)China Medical System Holdings (participant)Fenglei Capital (participant)Shanghai Sci-Tech Innovation Center Capital (participant)Canton Capital (participant)Root Venture Partners (participant)Vesey Ventures LP (lead)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Beyang Closes Oversubscribed $30 Million Series A Financing”
Investors on record
8 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Aug 12, 2026
    Beyang announced Series A of $30,000,000, led by Legend Capital, Shanghai Healthcare Capital
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company